Boston Trust Walden Corp Abb Vie Inc. Transaction History
Boston Trust Walden Corp
- $14.1 Billion
- Q3 2024
A detailed history of Boston Trust Walden Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Boston Trust Walden Corp holds 26,040 shares of ABBV stock, worth $4.3 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
26,040
Previous 25,756
1.1%
Holding current value
$4.3 Million
Previous $4.42 Million
16.41%
% of portfolio
0.04%
Previous 0.03%
Shares
28 transactions
Others Institutions Holding ABBV
# of Institutions
3,841Shares Held
1.25BCall Options Held
16.8MPut Options Held
12.2M-
Vanguard Group Inc Valley Forge, PA172MShares$28.3 Billion0.62% of portfolio
-
Black Rock Inc. New York, NY136MShares$22.5 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.1MShares$13 Billion0.65% of portfolio
-
Jpmorgan Chase & CO New York, NY52.1MShares$8.6 Billion0.84% of portfolio
-
Morgan Stanley New York, NY38.7MShares$6.39 Billion0.56% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $292B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...